ABCELLERA BIOLOGICS INC (ABCL) Institutional Ownership Changes & 13F Activity
ABCELLERA BIOLOGICS INC (ABCL). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Goldman Sachs Group Inc, Bank Of America Corp, Baker Bros. Advisors Lp, Alyeska Investment Group, L.P., and Price T Rowe Associates Inc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | Buy | +225,407 | +16.6% | 1,586,512 | $12.45M | Q2 2026 | Sep 02, 2026 |
| Goldman Sachs Group Inc | Sell | -3,516,085 | -93.7% | 235,127 | $1.85M | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Buy | +3,141,603 | +104.7% | 6,141,539 | $48.21M | Q2 2026 | Aug 14, 2026 |
| Baker Bros. Advisors Lp | Buy | +2,736,200 | +9.0% | 33,012,138 | $259.15M | Q2 2026 | Aug 14, 2026 |
| Alyeska Investment Group, L.P. | Sell | -2,065,528 | -79.7% | 526,577 | $4.13M | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Buy | +1,587,870 | — | 1,587,870 | $12.46M | Q2 2026 | Aug 14, 2026 |
| Driehaus Capital Management Llc | Sell | -1,160,050 | -28.8% | 2,864,729 | $22.49M | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Sell | -776,003 | -59.9% | 518,571 | $4.07M | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Sell | -729,813 | -97.3% | 20,580 | $161.55K | Q2 2026 | Aug 14, 2026 |
| Jane Street Group, Llc | Sell | -652,621 | -77.0% | 195,262 | $1.53M | Q2 2026 | Aug 14, 2026 |
| Voloridge Investment Management, Llc | Sell | -539,078 | -88.3% | 71,345 | $560.06K | Q2 2026 | Aug 14, 2026 |
| Hrt Financial Lp | Sell | -529,647 | -42.9% | 705,506 | $5.54M | Q2 2026 | Aug 14, 2026 |
| Sculptor Capital Lp | Buy | +454,000 | — | 454,000 | $3.56M | Q2 2026 | Aug 14, 2026 |
| Raymond James Financial Inc | Sell | -256,636 | -88.5% | 33,200 | $260.62K | Q2 2026 | Aug 14, 2026 |
| Man Group Plc | Buy | +228,979 | — | 228,979 | $1.80M | Q2 2026 | Aug 14, 2026 |
| Tudor Investment Corp Et Al | Sell | -210,298 | -9.3% | 2,063,191 | $16.20M | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Sell | -124,634 | -1.2% | 10,437,431 | $81.93M | Q2 2026 | Aug 14, 2026 |
| Exoduspoint Capital Management, Lp | Buy | +95,206 | +66.7% | 237,952 | $1.87M | Q2 2026 | Aug 14, 2026 |
| Caxton Associates Llp | Buy | +66,378 | — | 66,378 | $521.07K | Q2 2026 | Aug 14, 2026 |
| Voleon Capital Management Lp | Sell | -63,151 | -51.5% | 59,396 | $466.26K | Q2 2026 | Aug 14, 2026 |
| Osaic Holdings, Inc. | Buy | +58,920 | +16.9% | 407,898 | $3.20M | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +49,753 | — | 49,753 | $390.56K | Q2 2026 | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | Buy | +45,431 | — | 45,431 | $356.63K | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Buy | +44,435 | +279.5% | 60,335 | $473.63K | Q2 2026 | Aug 14, 2026 |
| Group One Trading Llc | Sell | -40,340 | -16.9% | 198,793 | $1.56M | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Buy | +35,160 | +71.1% | 84,634 | $664.38K | Q2 2026 | Aug 14, 2026 |
| Oxford Asset Management Llp | Buy | +31,064 | — | 31,064 | $243.85K | Q2 2026 | Aug 14, 2026 |
| Hsbc Holdings Plc | Sell | -25,542 | -17.8% | 117,930 | $929.29K | Q2 2026 | Aug 14, 2026 |
| Scientech Research Llc | Buy | +15,404 | — | 15,404 | $120.92K | Q2 2026 | Aug 14, 2026 |
| Ausdal Financial Partners, Inc. | Buy | +15,167 | — | 15,167 | $119.06K | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about ABCL activity
Which institutional owners are buying ABCL?
Institutional owners buying ABCL include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in ABCL activity?
"Buy" means an investor increased their reported position in ABCL compared to the prior reporting period. This reflects growing exposure to ABCELLERA BIOLOGICS INC (ABCL) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in ABCL increasing?
Institutional interest in ABCL can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related ABCL Institutional Insights
- ABCL Overview
- ABCL 13F Institutional Holders
- ABCL Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- ABCL Insider Trading & SEC Form 4 Activity
- ABCL Articles
- Top Institutional Investor Stock Rankings